Taxotere

In the US, Taxotere (docetaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Gastric Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and Solid Tumors.

US matches:

• Taxotere

UK matches:

• Taxotere 20 mg
• Taxotere 80 mg
• TAXOTERE 20 mg/1ml and 80mg/4ml and 160 mg/8ml concentrate for solution for infusion (SPC)
• Taxotere 20mg and 80mg concentrate and solvent for infusion (SPC)

Ingredient matches for Taxotere

Docetaxel

Docetaxel is reported as an ingredient of Taxotere in the following countries:

• Australia


• Bangladesh


• Bosnia & Herzegowina


• Canada


• Denmark


• Dominican Republic


• Ghana


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Kenya


• Luxembourg


• Malaysia


• Nigeria


• Norway


• Oman


• Peru


• Romania


• Russian Federation


• Serbia


• Slovakia


• Slovenia


• Spain


• Taiwan


• Thailand


• Tunisia


• Turkey


• Uganda


• United States


• Venezuela


• Vietnam


• Zimbabwe

Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Taxotere in the following countries:

• Argentina


• Austria


• Belgium


• Benin


• Brazil


• Burkina Faso


• Cameroon


• Chile


• Colombia


• Congo


• Costa Rica


• Cote D'ivoire


• Croatia (Hrvatska)


• Czech Republic


• Dominican Republic


• Ecuador


• El Salvador


• Finland


• France


• Gabon


• Georgia


• Germany


• Greece


• Guatemala


• Guinea


• Honduras


• Iceland


• Japan


• Mali


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Panama


• Poland


• Portugal


• Senegal


• Singapore


• South Africa


• Sweden


• Switzerland


• Togo


• United Kingdom


• Zaire

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.